Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism GRK5 inhibitors(GRK5 protein kinase inhibitors), GRK6 antagonists(G protein-coupled receptor kinase 6 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 3 | US | 12 Dec 2019 |